Yuyu Pharma, Inc. (KRX:000220)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,290.00
-30.00 (-0.69%)
Apr 29, 2026, 3:30 PM KST
-7.44%
Market Cap 67.56B
Revenue (ttm) 140.88B
Net Income (ttm) 8.15B
Shares Out 15.75M
EPS (ttm) 481.00
PE Ratio 8.92
Forward PE n/a
Dividend 100.00 (2.31%)
Ex-Dividend Date Dec 29, 2025
Volume 42,930
Average Volume 47,059
Open 4,280.00
Previous Close 4,320.00
Day's Range 4,255.00 - 4,320.00
52-Week Range 4,000.00 - 5,100.00
Beta 0.43
RSI 51.10
Earnings Date Apr 3, 2026

About Yuyu Pharma

Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea. [Read more]

Sector Healthcare
Founded 1941
Employees 254
Stock Exchange Korea Stock Exchange
Ticker Symbol 000220
Full Company Profile

Financial Performance

In 2025, Yuyu Pharma's revenue was 140.88 billion, an increase of 5.81% compared to the previous year's 133.15 billion. Earnings were 8.15 billion, a decrease of -6.49%.

Financial Statements

News

There is no news available yet.